Cara Therapeutics Inc (CARA)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

4 STAMFORD PLAZA STAMFORD, CT 06902

Cara Therapeutics, Inc. develops therapeutics. The Company offers novel drugs for the treatment of human diseases associated with pain and inflammation. Cara Therapeutics serves customers in the United States.

Data based on most recent fiscal year report
Market Cap675.306 Million Shares Outstanding40.03 Million Avg Volume968.5 Thousand
1-Yr BETA vs S&P TR1.667 Current Ratio4.16 Quick Ratio4.16
View SEC Filings from CARA instead.

View recent insider trading info

Funds Holding CARA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CARA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

44.4 Thousand total shares from 7 transactions

Exercise Derivative Conversion (M)

5 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

IVES JEFFREY L.

  • Director
6,000 2020-01-02 8

CHALMERS DEREK T PRESIDENT & CEO

  • Officer
  • Director
917,769 2020-01-02 10

MAKARA RICHARD VP, HEAD OF ACCTING;CONTROLLER

  • Officer
1,000 2019-12-20 1

TERRILLION SCOTT SEC'Y; CHIEF COMPLIANCE & G.C.

  • Officer
16,769 2019-12-02 3

MOHINDRU MANI CFO & CHIEF STRATEGY OFFICER

  • Officer
17,441 2019-12-02 5

MENZAGHI FREDERIQUE PH.D. CHIEF SCIENTIFIC OFF,SVP-R&D

  • Officer
63,886 2019-10-25 13

BAINS HARRISON M JR

  • Director
6,000 2019-06-04 1

VOGELBAUM MARTIN

  • Director
6,000 2019-06-04 2

POSNER CHRISTOPHER

  • Director
6,000 2019-06-04 1

GONCALVES JOANA CHIEF MEDICAL OFFICER

  • Officer
0 2018-10-22 0

STAUFFER JOSEPH WILLIAM CHIEF MEDICAL OFFICER

  • Officer
2,000 2018-10-17 0

SCHOELL JOSEF CHIEF FINANCIAL OFFICER

  • Officer
50,000 2017-07-26 0

SLAGEL DEAN

  • Director
1,064,338 2017-06-29 0

RHO VENTURES VI LP

RMV VI, L.L.C.

RHO CAPITAL PARTNERS LLC

LESCHLY MARK

KAIROUZ HABIB

RUCH JOSHUA

  • 10% Owner
3,568,057 2017-03-31 0

LEWIS MICHAEL E CHIEF SCIENTIFIC ADVISOR

  • Officer
0 2017-03-08 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

IVES JEFFREY L. - Director

2020-01-02 S 2,500 $16.13 d 6,000 6,000.00 direct yes

CHALMERS DEREK T - Director - Officer PRESIDENT & CEO

2020-01-02 S 10,000 $16.05 d 917,769 917,769.00 direct yes

IVES JEFFREY L. - Director

2020-01-02 M 2,500 $9.94 a 8,500 6,000.00 direct yes

IVES JEFFREY L. - Director

2020-01-02 M 2,500 d 11,000 6,000.00 direct yes

CHALMERS DEREK T - Director - Officer PRESIDENT & CEO

2019-12-04 S 10,699 $17.05 d 927,769 927,769.00 direct yes

MOHINDRU MANI - Officer CFO & CHIEF STRATEGY OFFICER

2019-12-04 S 4,755 $17.05 d 17,441 17,441.00 direct yes

TERRILLION SCOTT - Officer SEC'Y; CHIEF COMPLIANCE & G.C.

2019-12-04 S 3,980 $17.05 d 16,769 16,769.00 direct yes

CHALMERS DEREK T - Director - Officer PRESIDENT & CEO

2019-12-02 S 10,000 $25.79 d 918,468 927,769.00 direct yes

TERRILLION SCOTT - Officer SEC'Y; CHIEF COMPLIANCE & G.C.

2019-12-02 A 8,333 a 20,749 16,769.00 direct

IVES JEFFREY L. - Director

2019-12-02 M 2,500 d 0 6,000.00 direct yes

IVES JEFFREY L. - Director

2019-12-02 S 2,500 $25.83 d 6,000 6,000.00 direct yes

CHALMERS DEREK T - Director - Officer PRESIDENT & CEO

2019-12-02 A 20,000 a 938,468 927,769.00 direct

MOHINDRU MANI - Officer CFO & CHIEF STRATEGY OFFICER

2019-12-02 A 8,333 a 22,196 17,441.00 direct

IVES JEFFREY L. - Director

2019-12-02 M 2,500 $5.32 a 8,500 6,000.00 direct yes
Click here to report any possible errors with this stock listing.

Elevate your investments